earnings

NASDAQ · BOLD
Boundless Bio, Inc.
Healthcare · Biotechnology
$2.78
Down-$0.01 (-0.18%)
Updated Aug 14, 2026, 2:56 PM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 25.74M
- P/E ratio
- -0.4
- Dividend yield
- 0.00%
- 52-week range
- $1.07 – $2.97
- Volume
- 159.81K
- Avg. volume
- 159.75K
Price performance
BOLD price history
1M range · 21 trading sessions · Daily adjusted prices
BOLD closed at $2.78 after 21 trading sessions, up 11.45% for the selected period.
- Last close
- $2.78
- Period change
- +11.45%
- Period low
- $2.44
- Period high
- $2.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $2.80 | $2.85 | $2.75 | $2.775 | 159.81K |
| Aug 12, 2026 | $2.78 | $2.88 | $2.72 | $2.78 | 252.61K |
| Aug 11, 2026 | $2.83 | $2.89 | $2.74 | $2.75 | 297.49K |
| Aug 10, 2026 | $2.92 | $2.97 | $2.815 | $2.82 | 434.53K |
| Aug 7, 2026 | $2.80 | $2.90 | $2.725 | $2.89 | 940.38K |
| Aug 6, 2026 | $2.80 | $2.90 | $2.80 | $2.84 | 297.96K |
| Aug 5, 2026 | $2.72 | $2.92 | $2.72 | $2.80 | 527.37K |
| Aug 4, 2026 | $2.55 | $2.75 | $2.55 | $2.705 | 377.26K |
| Aug 3, 2026 | $2.49 | $2.61 | $2.48 | $2.57 | 318K |
| Jul 31, 2026 | $2.53 | $2.57 | $2.48 | $2.50 | 105.47K |
| Jul 30, 2026 | $2.49 | $2.55 | $2.49 | $2.50 | 99.09K |
| Jul 29, 2026 | $2.47 | $2.50 | $2.45 | $2.48 | 71.71K |
| Jul 28, 2026 | $2.46 | $2.48 | $2.43 | $2.47 | 137.85K |
| Jul 27, 2026 | $2.57 | $2.60 | $2.46 | $2.48 | 121.47K |
| Jul 24, 2026 | $2.53 | $2.60 | $2.525 | $2.57 | 194.56K |
| Jul 23, 2026 | $2.52 | $2.58 | $2.45 | $2.52 | 375.54K |
| Jul 22, 2026 | $2.48 | $2.635 | $2.465 | $2.52 | 281.01K |
| Jul 21, 2026 | $2.44 | $2.5189 | $2.44 | $2.48 | 96.87K |
| Jul 20, 2026 | $2.47 | $2.495 | $2.44 | $2.44 | 101.94K |
| Jul 17, 2026 | $2.50 | $2.505 | $2.44 | $2.48 | 102.93K |
| Jul 16, 2026 | $2.47 | $2.56 | $2.42 | $2.49 | 137.75K |
Latest BOLD news
The latest Smart Investors Daily articles mentioning BOLD.
Stock researchCompany · Financials
Loading stock research…

